Overview
π Website:
π² Revenue:
π Address:
π₯ Employees:
ποΈ Established: 2013
π Published: December 8, 2025
βοΈ Last updated: October 17, 2026
π Website:
π² Revenue:
π Address:
π₯ Employees:
ποΈ Established: 2013
π Published: December 8, 2025
βοΈ Last updated: October 17, 2026
AskAI Summary of Recursion Pharmaceuticals, Inc.
Generated using ISVWorld's AskAI proprietary software industry model.
π AskAI Recap: A clinical-stage TechBio company that uses AI, proprietary biological data, and automation to discover and develop medicines.
π¬ Inclusion Rationale: Recursion is classified as an ISV because it publicly offers reusable software assets, including the OpenPhenom-S/16 foundation model and the Boltz-2 model/trainer, which external users can access and use. The companyβs biotech and drug-discovery services are prominent, but the presence of these externally available software assets is sufficient for ISV classification.
Based on AskAI classifications for Recursion Pharmaceuticals, Inc., ISVWorld identifies comparable software companies in the same revenue range, related software categories, and major geographic regions. This view helps compare Recursion Pharmaceuticals, Inc. with active ISVs and software vendors across AI-ML Platforms, Developer Tools, Open Source Software markets.
27
Active software companies in the $50M to $100M revenue range classified under AI-ML Platforms.
485
Active software companies in the $50M to $100M revenue range classified under Developer Tools.
34
Active software companies in the $50M to $100M revenue range classified under Open Source Software.
28,486
Active software companies in North America matching any of Recursion Pharmaceuticals, Inc.'s AskAI classifications.
24,057
Active software companies in Europe matching any of Recursion Pharmaceuticals, Inc.'s AskAI classifications.
12,602
Active software companies in Asia matching any of Recursion Pharmaceuticals, Inc.'s AskAI classifications.